Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NVS - Incyte: An Undervalued Biotech With Catalysts

NVS - Incyte: An Undervalued Biotech With Catalysts

Novartis AG

Background

I turned bearish on Incyte (INCY) in early May 2017, with summary comments in an article on it including the following:

  • Even though the stock looked good in the $117-118 range on the way up a few months ago, there are more negatives now...
  • Thus, while INCY is "in play" and may attract a takeover bid, I'm less positive on its $25 B valuation than I might have been, and am not buying yet.

Now, INCY is down to the $83-74 range even though the S&P 500 (SPY) is much

Read more ...
Stock Information
Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com
Menu
NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...